Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy
US-11974992-B2 · May 7, 2024 · US
Neurolixis holds 2 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 2 |
| Recent patents | 2 |
| First publication | Jul 27, 2023 |
| Latest publication | May 7, 2024 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
Representative or frequently cited publications from precomputed assignee stats.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 2 |